In light of the incessant healthcare talk and reform on the imminent horizon, we’ve lately had fun discovering tiny new companies that illustrate some of the under-the-radar efforts of the medical community that might help reduce the cost of what has become a behemoth. (Oh, Congress, are you listening?) This week, that company [...]
There’s good news today for the more than 30,000 people receiving life-saving kidney transplants globally each year. Carlsbad, California-based Invitrogen aims to improve life after transplant with a new biomarker tool that addresses two chronic and life-threatening challenges: kidney rejection triggered by the graft and the cumulative cell and tissue damage caused by immunosuppressive drugs [...]
Life sciences took two of the five spots in this week’s Startup Watch from Mass High Tech. The first company spotlighted as one to watch is a unique pharmaceutical company out of Maine called Putney that specializes in drugs for pets. The company says it focuses on developing generics for frequently used drugs where cost [...]
We’ve seen a lot of ink dedicated to cloud computing in the life sciences press over the past six months, so it seems like it is past time to acknowledge the buzz and take a closer look at some of the issues surrounding this latest movement. Genome Technology’s overview of the trend, published today [...]
FierceBiotech today released its annual Fierce 15 list of the top fifteen emerging biotech companies, and editor John Carroll’s commentary on this year’s selection process was a bit surprising. In contrast to his initial fear, he says it was unexpectedly easy to find the top outfits, even given the rather disheartening state of the [...]
A Cambridge-based biopharma, developing a revolutionary class of drugs called Stapled Peptides, received some major backing from big pharma today. Fierce Biotech reported that Aileron Therapeutics landed $40 million in Series D funding from the venture arms of four of the world’s biggest pharma companies, including SR One (the corporate venture fund of GlaxoSmithKline), Novartis [...]
Everyone likes a great idea, and some have more resources to foster them than others. In a move that pits big business against academia which he termed prone to “academic snobbery”, GlaxoSmithKline Chief Executive Andrew Witty said this week that the company is considering adding new facilities at its main research sites aimed at [...]
Medford based Ancora Pharmaceuticals, former winner of the prestigious 2002 Robert P. Goldberg Business plan contest at MIT, announced this week that the National Institutes of Health (NIH) has awarded the company a $530,000 Phase 1 Small Business Innovation Research grant. The grant supports Ancora’s efforts to develop a vaccine to prevent malaria anemia. [...]
We’ve become accustomed to hearing about advancements in the life sciences industry from places like California, Massachusetts and North Carolina, but today’s interesting news clip comes from, drum roll please…Alabama. You may be asking yourself, just what new and exciting company is on the horizon in Alabama? Well, the answer is several; at least that’s [...]
Really cool news out of the UK today: experts there claim they are on the verge of perfecting a tiny mobile phone microchip to diagnose medical conditions on the spot. According to execs at Orla Protein Technologies and Tokyo-based Japan Radio Company, the diminutive device will read swabs and blood tests and slot into a [...]